期刊论文详细信息
BMC Complementary and Alternative Medicine
Prevention of allergic airway hyperresponsiveness and remodeling in mice by Astragaliradix Antiasthmatic decoction
Hua-Hao Shen1  Wen Li2  Zhi-Hua Chen2  Li-Xia Xia2  Wen Hua2  Lan-Hong Zhang2  Bao-Ping Tian2  Su Xu2 
[1] State Key Laboratory of Respiratory Diseases, Guangzhou 510120, China;Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Medicine, 88 Jiefang Rd., Hangzhou 310009, China
关键词: Airway remodeling;    Airway hyperresponsiveness;    Astragalus Antiasthmatic Decoction;   
Others  :  1220417
DOI  :  10.1186/1472-6882-13-369
 received in 2013-05-13, accepted in 2013-11-29,  发布年份 2013
PDF
【 摘 要 】

Background

Astragali radix Antiasthmatic Decoction (AAD), a traditional Chinese medication, is found effective in treating allergic diseases and chronic cough. The purpose of this study is to determine whether this medication could suppress allergen-induced airway hyperresponsiveness (AHR) and remodeling in mice, and its possible mechanisms.

Methods

A mouse model of chronic asthma was used to investigate the effects of AAD on the airway lesions. Mice were sensitized and challenged with ovalbumin (OVA), and the extent of AHR and airway remodeling were characterized. Cells and cytokines in the bronchoalveolar lavage fluid (BALF) were examined.

Results

AAD treatment effectively decreased OVA-induced AHR, eosinophilic airway inflammation, and collagen deposition around the airway. It significantly reduced the levels of IL-13 and TGF-β1, but exerted inconsiderable effect on INF-γ and IL-10.

Conclusions

AAD greatly improves the symptoms of allergic airway remodeling probably through inhibition of Th2 cytokines and TGF-β1.

【 授权许可】

   
2013 Xu et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150722055933746.pdf 1776KB PDF download
Figure 5. 46KB Image download
Figure 4. 183KB Image download
Figure 3. 145KB Image download
Figure 2. 23KB Image download
Figure 1. 31KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】
  • [1]Barnes PJ: Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008, 8:183-192.
  • [2]Al-Muhsen S, Johnson JR, Hamid Q: Remodeling in asthma. J Allergy Clin Immunol 2011, 128:451-462.
  • [3]Ngoc PL, Gold DR, Tzianabos AO, Weiss ST, Celedón JC: Cytokines, allergy, and asthma. Curr Opin Allergy Clin Immunol 2005, 5:161-166.
  • [4]Kumar RK, Webb DC, Herbert C, Foster PS: Interferon-gamma as a possible target in chronic asthma. Inflamm Allergy Drug Target 2006, 5:253-256.
  • [5]Akdis CA, Akdis M: Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 2009, 123:735-746.
  • [6]RayA KA, Krishnamoorthy N, Qi Z, Ray P: Regulatory T cells in many flavors control asthma. Mucosal Immunol 2100, 3:216-229.
  • [7]Bedir E, Pugh N, Calis I, Pasco DS, Khan IA: Immunostimulatory effects of cycloartane-type triterpene glycosides from astragalus species. Biol Pharm Bull 2000, 23:834-837.
  • [8]Block KI, Mead MN: Immune system effects of echinacea, ginseng, and astragalus: a review. Integr Cancer Ther 2003, 2:247-267.
  • [9]Shen HH, Wang K, Li W, Ying YH, Gao GX, Li XB, Huang HQ: Astragalus Membranaceus prevents airway hyperreactivity in mice related to Th2 response inhibition. J Ethnopharmacol 2008, 116:363-369.
  • [10]Gao GX, Li QM, Shen HH: Effect of Astragali-Cordyceps Mixtura on TGF-beta/Smad signal pathway in the lung of asthma airway remodeling. J Ethnopharmacol 2009, 125:68-74.
  • [11]Wang HJ: Therapeutic effects of Astragalus L. Antiasthmatic decoction in asthma. Lin Chuang Yi Xue (Chinese) 2011, 31:122.
  • [12]Wang PL, Zhang GS, Qin XJ, Qiu ZW, LiN , Chen ZH, Li W, Shen HH: Inhibition of allergen-induced airway remodeling by neonatal bacillus Calmette-Guerin vaccination is associated with interferon-gamma-producing T cells but not regulatory T cells in mice. Ann Allergy Asthma Immunol 2011, 107:163-170.
  • [13]Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD: Interleukin-13: central mediator of allergic asthma. Science 1998, 282:2258-2261.
  • [14]Cohn L, Homer RJ, Marinov A, Rankin J, Bottomly K: Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med 1997, 186:1737-1747.
  • [15]Grünig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, Corry DB: Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998, 282:2261-2263.
  • [16]Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA: Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999, 103:779-788.
  • [17]Kenyon NJ, Ward RW, McGrew G, Last JA: TGF-beta1 causes airway fibrosis and increased collagen I and II mRNA in mice. Thorax 2003, 58:772-777.
  • [18]Duvernelle C, Freund V: Frossard N:Transforming growth factor- beta and its role in asthma. Pulm Pharmacol Ther 2003, 16:181-196.
  • [19]Chakir J, Shannon J, Molet S, Fukakusa M, Elias J, Laviolette M, Boulet LP, Hamid Q: Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 2003, 111:1293-1299.
  • [20]Zhou MY: Shen Ling Bai Zhu San in treatment of 125 cases with infections in the upper respiratory tract. Sci Technol Chin Mater Medica 2001, 8:68.
  • [21]Ok IS, Kim SH, Kim BK, Lee JC, Lee YC: Pinellia ternata, Citrus reticulata, and their combinational prescription inhibit eosinophil infiltration and airway hyperresponsiveness by suppressing CCR3+ and Th2 cytokines production in the ovalbumin-induced asthma model. Mediators Inflamm 2009, 2009:413270.
  • [22]Lau KM, Fu LH, Cheng L, Wong CW, Wong YL, Lau CP, Han SQ, Chan PK, Fung KP, Lau CB, Hui M, Leung PC: Two antifungal components isolated from Fructus Psoraleae and Folium Eucalypti Globuli by bioassay-guided purification. Am J Chin Med 2010, 38:1005-1014.
  • [23]Li JP, Liang ZM, Yuan Z: Triterpenoid saponins and anti-inflammatory activity of Codonopsis lanceolata. Pharmazie 2007, 62:463-466.
  • [24]He B, Zhang YT, Yuan XG, Sun JS, Wei GH, Lin T: Protective effects of Radix Codonopsis on ischemia-reperfusion injury in rats after kidney transplantation. Pediatr Surg Int 2011, 27:1203-1212.
  • [25]Yen FL, Wu TH, Lin LT, Lin CC: Hepatoprotective and antioxidant effects of Cuscuta chinensis against acetaminophen-induced hepatotoxicity in rats. J Ethnopharmacol 2007, 111:123-128.
  • [26]Lin MK, Yu YL, Chen KC, Chang WT, Lee MS, Yang MJ, Cheng HC, Liu CH, DzC C, Chu CL: Kaempferol from Semen cuscutae attenuates the immune fiunction of dendritic cells. Immunology 2011, 216:1103-1109.
  • [27]Huang T, Shen P, Shen Y: Preparative separation and purification of deoxyschisandrin and gamma-schisandrin from Schisandra chinensis (Turcz.) Baill by high-speed counter-current chromatography. J Chromatogr A 2005, 1066:239-242.
  • [28]Yi LZ, Yuan DL, Liang YZ, Xie PS, Zhao Y: Quality control and discrimination of Pericarpium Citri Reticulatae and Pericarpium Citri Reticulatae Viride based on high-performance liquid chromatographic fingerprints and multivariate statistical analysis. Anal Chim Acta 2007, 588:207-215.
  • [29]Zhao B, Yang XB, Yang XW, Wu Q, Wang Y, Zhang LX, Xu W: Intestinal permeability of the constituents from the roots of Saposhnikovia divaricata in the human Caco-2 cell monolayer model. Planta Med 2011, 77:1531-1535.
  文献评价指标  
  下载次数:22次 浏览次数:8次